Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AACS	"ACSF1, FLJ12389, SUR-5"	ENSG00000081760	"Acetoacetyl-CoA synthetase"	Q86V21	12	125065379-125143333	"Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058815	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA058815: AB_2683826"	"unprognostic (1.28e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-3)"	"unprognostic (6.60e-6)"	"unprognostic (3.03e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (7.71e-2)"	"unprognostic (6.80e-2)"	21.1	6.5	9.0	10.5	13.0	2.5	33.7	6.6	22.0	11.7	9.3	5.3	7.4	12.9	5.2	7.7	22.3	6.6	12.9	5.8	8.1	5.6	6.8	3.3	4.9	4.9	5.1	13.1	4.9	9.7	5.8	6.7	4.8	10.0	6.7	8.6	5.1	33.7	12.9	3.7	26.9	8.7	4.5	4.2	4.3	12.7	9.7	3.6	6.8	7.6	12.2	8.7	5.0	9.9	3.0	11.8	6.9	2.3	5.8	5.7	3.8	14.5	14.5	6.3	8.6	23.4	15.3	10.6	11.8	11.3	14.0	12.6	18.7	9.7	9.0	12.2	14.2	6.1	15.9	11.8	12.7	7.6	9.7	10.8	7.2	9.7	14.2	19.5	5.1	7.3	16.9	10.4	11.9	12.1	17.6	10.2	5.3	5.0	5.6	8.9	26.6	5.9	6.8	8.0	15.3	17.2	1.1	16.1	12.4	14.3	22.2	17.0	4.9	12.5	19.8	9.1	6.5	14.8	11.3	9.7	6.8	10.8	7.6	9.0	12.7	7.2	9.8	8.5	8.4	7.4	6.9	2.3	6.7	4.2	0.7	5.4	3.0	3.9	3.2	2.8	1.7	5.7	3.8	0.3	5.8	0.8	11.8	2.4	3.8	9.0	13.0	6.6	22.0	8.1	5.6	5.1	13.1	10.0	3.6	6.0	12.9	0.8	4.9	14.7	16.4	7.3	12.7	0.0	5.7	5.2	25.5	1.8	6.6	9.5	54.0	5.8	9.9	0.0	9.5	7.4	11.4	9.4	2.3	2.5	4.1	6.4	24.2	0.6	3.2	14.6	8.6	2.8	5.0	5.4	20.1	5.4	8.7	5.8	4.9	6.2	20.1	0.0	7.6	12.7	5.4	24.6	2.1	9.2	15.1	4.9
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 168.5;Exocrine glandular cells: 155.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 48.1"					"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.7	6.3	42.7	16.3	6.1	11.3	1.4	5.9	7.1	14.1	24.4	24.5	8.6	5.6	3.0	4.7	48.1	6.5	17.7	46.2	16.7	3.3	18.1	13.1	10.2	40.6	6.1	7.6	3.5	6.1	3.4	23.3	10.0	2.1	6.9	16.0	14.1	9.6	8.5	11.9	13.0	12.1	14.3	6.7	4.6	8.1	9.6	17.4	32.9	8.7	11.4	6.5	6.9	4.5	2.4	2.0	8.5	15.1	4.3	5.2	4.5	7.3	15.2	4.6	8.4	13.8	1.5	14.9	7.8	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2											11.9	35.5	24.6	29.0	23.2	14.0	1.2	40.8	20.1	21.6	19.2	2.0	44.4	59.7	47.3	168.5	10.9	23.5	0.0	155.7	84.2	22.6	31.4	12.7	55.7	46.8	12.7	16.4	12.9	10.5	110.0	12.7	23.1	28.7	92.8	21.4	21.8	47.0	17.5	18.0	33.8	19.6	0.0	34.0	14.7	48.7	18.3	29.4	26.6	23.3	27.6
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 149.0"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 367.9;Hofbauer cells: 155.3;monocytes: 143.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 176.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 38.2;neutrophil: 30.6"	"Group enriched"	"Detected in many"	20	"granulocytes: 30.6;monocytes: 38.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 74.3;HSkMC: 14.2;RPTEC TERT1: 18.9;SK-MEL-30: 30.5;WM-115: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	14.4	12.3	6.3	4.7	13.4	0.7	5.5	2.4	7.5	6.5	21.9	16.9	24.9	21.0	5.0	5.4	3.5	9.2	5.1	6.9	8.3	6.2	12.6	149.0	22.4	5.6	19.9	5.7	9.5	2.4	6.3	7.1	2.0	12.1	11.6	6.0	15.1	10.0	21.5	10.0	3.9	36.8	5.0	18.8	3.1	3.5	3.7	15.7	3.7	3.1	4.0	7.6	5.5	5.7	0.1	1.7	30.6	38.2	0.0	0.1	10.0	0.0	0.0	0.7	0.0	1.3	0.9	0.1	0.8	3.0	1.0	2.1	3.7	0.1	0.0	1.5	2.1	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.0	0.1	74.3	4.3	0.1	0.0	14.2	0.1	0.0	0.0	3.5	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.7	0.1	18.9	0.0	0.0	0.0	0.0	0.0	30.5	0.7	0.5	0.7	1.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.9	0.0	38.2	0.1	0.0	4.3	0.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	30.6	0.0	0.3	0.2	0.0	10.0	6.3	13.4	2.4	7.5	8.3	6.2	19.9	5.7	12.1	15.7	3.0	28.2	0.9	44.4	4.6	13.8	5.0	17.8	14.7	12.5	3.5	25.5	0.9	8.3	9.2	0.9	7.1	46.1	0.0	10.8	0.5	20.2	45.1	2.3	367.9	155.3	9.5	23.5	19.6	15.9	0.6	44.0	31.1	47.2	143.3	9.0	29.6	6.6	19.3	25.1	66.2	13.7	0.0	8.5	0.3	0.0	2.8	1.0	2.5	18.7	20.0
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.4
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500236	"Enzymes, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	70	"liver: 50.4"	"Cell type enriched"	"Detected in single"	12	"Hepatocytes: 4.7"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.2	0.5	0.0	0.4	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849633-54887218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 164.5;liver: 119.6"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 733.4;Hepatocytes: 888.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA					"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"	10.6	164.5	6.6	3.9	22.1	0.7	22.0	6.5	27.5	7.7	11.1	43.8	1.2	11.9	2.2	1.1	40.8	12.3	8.6	3.7	12.0	9.2	6.4	119.6	40.9	2.0	36.2	13.0	7.8	4.6	28.4	2.6	4.4	47.9	26.1	8.3	4.8	20.2	2.1	24.6	47.6	7.3	2.7	71.7	24.3	17.6	14.1	31.1	1.7	4.3	17.1	14.3	2.5	13.0	5.4	7.0	7.3	3.1	3.7	9.0	5.5	40.5	7.5	26.5	32.0	132.8	28.6	6.2	11.7	20.3	16.9	34.9	41.6	25.7	6.5	23.6	10.2	53.9	39.0	31.7	61.7	15.1	0.9	19.9	36.1	17.7	49.7	21.6	15.0	8.4	20.8	53.9	52.2	9.7	8.3	8.3	15.3	26.3	0.0	6.2	17.0	3.2	13.2	73.3	11.0	20.5	0.0	6.7	19.9	92.9	32.9	18.3	6.7	22.2	42.0	15.3	29.3	54.7	17.5	7.6	5.6	16.5	8.1	22.1	2.8	6.4	11.2	4.1	25.9	7.3	7.3	2.4	1.1	9.0	3.1	0.5	5.4	4.0	4.2	7.0	2.4	3.9	4.7	0.1	3.7	1.0	4.2	0.7	5.5	6.6	22.1	6.5	27.5	12.0	9.2	36.2	13.0	47.9	31.1	276.9	733.4	19.9	13.4	27.9	4.4	9.0	165.6	95.0	154.7	64.6	0.0	33.0	3.3	46.7	12.8	10.6	64.2	93.5	65.4	27.5	19.8	70.0	30.2	888.0	22.6	4.8	23.1	154.7	70.4	40.3	13.0	6.1	13.5	10.8	30.6	3.7	38.4	26.0	7.4	11.2	4.4	0.0	4.7	1.7	14.0	70.3	25.6	7.0	24.8	34.0
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.8"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 43.9;Hepatocytes: 67.2;Syncytiotrophoblasts: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"	8.0	40.1	12.1	5.6	14.5	19.0	16.8	5.3	22.8	5.5	9.3	27.9	8.8	20.8	4.0	27.3	14.6	5.2	5.8	10.7	13.7	13.2	7.1	64.8	12.0	2.7	20.6	12.3	21.5	7.3	14.0	7.0	3.7	23.4	10.0	6.6	16.6	10.0	3.9	5.4	22.9	15.8	4.5	20.5	5.9	8.5	17.7	15.5	2.8	5.4	12.1	7.7	4.3	7.4	6.3	6.2	3.5	1.9	4.6	12.1	5.7	21.2	19.3	18.9	20.9	8.9	13.8	5.9	8.8	23.5	7.5	20.5	71.9	70.0	14.9	14.0	8.4	67.3	41.0	22.5	47.6	7.9	5.6	16.9	5.7	16.3	30.7	22.8	10.6	2.7	15.9	21.1	28.2	19.4	6.2	11.1	19.5	26.6	31.8	7.5	57.2	8.7	12.0	27.1	21.1	11.5	7.9	26.6	64.0	28.2	32.2	25.7	9.6	8.4	27.8	20.0	9.6	26.9	5.8	10.4	2.0	11.4	0.6	10.5	10.5	12.7	15.9	6.0	18.9	8.5	3.5	1.9	1.7	9.7	1.2	11.8	6.3	8.2	9.0	2.5	5.4	10.5	12.1	1.0	4.6	1.2	6.2	5.1	5.7	12.1	14.5	5.3	22.8	13.7	13.2	20.6	12.3	23.4	15.5	3.0	12.6	6.7	7.1	0.7	6.8	11.3	10.2	5.3	9.1	21.0	11.8	13.8	6.6	29.1	0.1	6.6	7.8	0.0	43.9	21.8	9.3	14.2	0.0	67.2	9.8	0.0	9.1	6.2	3.7	0.0	7.8	3.0	5.0	9.0	11.8	20.9	19.8	7.0	4.6	2.9	8.0	12.9	2.5	0.6	5.9	1.0	45.3	10.2	14.5	7.1
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"Emopamil binding protein (sterol isomerase)"	Q15125	X	48521158-48528716	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease mutation, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 389.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003130	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"	3.7	33.2	5.3	4.3	5.7	10.5	10.5	10.1	6.3	8.6	19.6	2.8	3.4	17.2	4.0	3.7	20.6	3.9	4.5	21.7	4.7	4.3	12.8	74.1	14.9	13.0	3.5	8.0	4.8	11.7	6.0	3.7	4.2	8.8	8.6	15.7	5.2	8.7	4.8	3.5	9.1	30.0	5.6	7.0	7.9	8.1	5.4	2.8	9.0	4.6	9.8	10.4	5.0	10.0	17.1	22.9	21.5	12.6	13.3	29.9	18.1	33.6	7.1	18.9	11.3	10.5	7.8	6.1	8.6	7.2	11.5	16.6	14.1	56.2	18.2	6.1	6.0	11.3	37.9	31.6	46.7	8.7	14.0	15.8	9.2	9.5	12.1	7.7	33.8	22.8	7.6	17.0	15.3	11.4	2.9	7.6	12.9	11.7	17.3	9.4	14.7	18.8	20.7	19.0	9.7	23.4	13.0	1.9	51.6	28.1	6.0	16.1	8.1	31.8	16.4	4.5	12.6	18.0	8.1	8.0	5.9	10.0	22.7	9.4	7.4	11.6	18.4	13.7	34.1	5.6	17.4	8.9	21.5	29.9	11.7	25.1	17.1	22.2	27.5	12.3	12.6	20.1	25.5	1.8	13.3	12.6	22.9	22.4	18.1	5.3	5.7	10.1	6.3	4.7	4.3	3.5	8.0	8.8	2.8	29.8	39.6	41.7	45.2	33.0	23.7	36.3	81.5	22.7	21.6	50.6	7.9	40.6	33.2	80.2	5.4	24.3	135.6	46.7	207.1	93.9	32.6	42.4	40.3	389.0	57.0	7.9	28.8	28.8	26.6	7.8	12.4	34.4	35.4	47.7	72.4	13.4	126.3	129.8	13.8	76.4	15.9	12.9	20.6	8.6	20.0	39.6	31.4	74.7	134.2	61.7
FDFT1		ENSG00000079459	"Farnesyl-diphosphate farnesyltransferase 1"	P37268	8	11795573-11839309	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008874	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA008874: AB_1078844"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.57e-1)"	"prognostic favorable (6.59e-9)"	"unprognostic (2.28e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.06e-1)"	20.8	44.3	26.3	22.7	27.7	30.6	57.5	19.5	43.6	27.6	41.7	45.9	20.0	44.6	26.9	29.1	59.4	27.5	19.9	27.1	29.8	32.1	24.9	45.9	30.7	23.4	36.2	34.4	22.9	18.0	17.1	18.2	22.1	47.4	38.8	32.9	32.4	46.5	20.6	71.2	38.4	30.2	18.0	56.5	18.4	35.4	41.3	40.5	25.9	24.7	32.2	25.4	25.8	34.2	44.0	30.5	42.2	19.6	22.6	31.0	29.0	21.6	10.5	47.1	18.8	10.2	17.5	14.3	8.5	14.5	9.0	18.7	14.7	26.8	30.1	4.2	8.5	52.3	18.0	23.3	71.0	7.3	5.0	24.9	14.1	8.0	35.0	21.7	7.3	9.9	15.7	18.0	20.1	10.0	6.9	11.3	35.0	20.3	39.7	8.8	14.1	25.7	17.4	41.2	18.0	6.2	15.8	10.9	61.8	41.8	78.8	15.1	9.4	7.4	12.6	21.3	18.7	20.7	21.3	14.1	4.2	10.5	1.9	5.3	8.2	20.7	32.8	7.4	24.8	12.4	42.2	19.6	22.6	21.6	17.2	20.8	44.0	22.7	21.2	30.5	35.3	21.5	20.3	18.6	22.6	11.7	22.7	31.0	29.0	26.3	27.7	19.5	43.6	29.8	32.1	36.2	34.4	47.4	40.5	50.6	130.3	65.1	88.1	46.6	14.4	61.6	107.0	89.7	86.4	75.0	13.7	242.8	74.6	133.2	225.3	35.0	92.9	46.7	248.7	118.9	42.5	90.7	54.4	67.1	77.6	11.1	75.9	16.5	49.7	171.1	71.4	48.9	96.2	125.4	83.9	56.6	133.6	63.2	50.2	63.4	19.7	51.8	62.1	181.7	75.9	77.7	146.3	48.4	83.2	141.3
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	36.0	19.6	72.1	26.0	16.9	62.0	25.7	17.2	34.1	27.5	44.8	31.7	85.9	27.5	41.9	15.0	65.7	40.3	42.9	149.6	25.8	15.0	30.7	15.9	35.0	38.3	27.8	25.8	18.3	44.1	23.7	43.7	22.0	12.5	47.9	40.8	28.5	74.2	28.6	38.7	33.0	25.1	43.3	26.8	28.7	28.5	31.3	76.3	72.5	24.1	28.1	24.0	17.7	32.3	29.7	42.9	23.3	70.2	34.8	15.4	18.9	9.5	31.4	31.5	24.2	49.1	15.0	27.6	24.2	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5	68.5	144.0	64.8	78.5	32.6	65.5	1.4	107.0	85.6	83.0	50.6	58.9	177.4	116.0	154.2	171.3	113.0	197.2	93.5	286.2	162.6	57.3	89.5	62.2	111.9	95.6	52.4	68.5	133.8	57.6	52.3	56.4	56.4	91.1	217.4	74.5	75.0	194.9	143.8	66.1	113.5	78.0	71.1	63.8	41.9	15.5	52.2	120.0	77.8	106.3	110.3
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 164.1;Late spermatids: 214.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029472	Enhanced					NA	NA					"HPA029472: AB_10696206"	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.5	24.8	26.8	16.2	25.7	6.8	33.4	30.1	28.7	24.9	23.1	19.9	21.8	19.8	22.8	30.3	24.1	20.9	19.2	21.8	25.4	25.8	26.4	20.0	18.9	18.3	24.4	22.0	23.5	16.0	19.0	29.3	24.2	25.8	29.0	23.2	15.9	27.8	21.9	26.8	19.0	20.6	24.9	28.3	20.4	20.1	42.5	25.6	22.6	27.9	21.2	20.0	26.9	17.9	28.5	22.2	33.9	35.9	22.1	31.3	26.0	16.6	9.0	22.7	17.0	17.7	25.6	8.9	14.9	20.8	9.8	13.9	7.0	26.6	11.3	21.6	16.3	16.0	13.6	12.0	15.3	13.1	11.5	22.4	9.6	8.6	11.8	20.0	11.8	8.2	16.6	27.6	13.3	18.0	17.4	17.4	19.1	22.9	10.2	12.9	9.8	14.6	14.1	19.4	44.2	4.7	9.0	7.1	12.8	27.4	9.0	18.2	25.2	11.1	25.6	21.3	8.7	31.9	18.8	14.7	11.8	8.9	19.9	13.9	17.8	21.5	13.8	14.9	13.3	21.1	26.6	22.8	33.9	24.8	26.8	24.9	28.5	31.3	26.4	22.2	23.4	29.2	26.5	20.6	22.1	35.9	18.4	30.0	26.0	26.8	25.7	30.1	28.7	25.4	25.8	24.4	22.0	25.8	25.6	29.8	37.5	16.7	58.0	35.4	29.3	20.4	20.4	17.4	15.9	19.2	41.2	26.1	61.3	31.7	164.1	29.1	23.6	0.0	25.0	30.3	35.7	57.0	23.2	12.4	23.9	46.1	16.7	28.3	22.2	214.2	33.1	33.8	64.1	33.3	21.8	38.1	25.9	24.1	32.9	45.5	48.9	25.8	42.4	62.3	46.6	35.5	39.4	32.6	20.4	46.7
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 147.7;Proximal tubular cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"	NA	NA		120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.5	6.1	6.9	5.1	28.0	21.4	2.6	8.4	14.7	9.1	11.1	3.8	20.5	5.5	17.3	13.0	7.4	8.5	8.2	13.6	9.9	11.2	6.2	7.4	5.4	8.7	36.2	2.8	4.9	24.8	20.2	11.9	23.0	24.5	12.3	10.5	7.5	7.8	16.6	10.8	4.5	5.7	1.7	28.9	8.5	6.4	5.6	10.2	21.4	5.5	5.8	5.1	10.9	4.1	18.5	9.5	13.0	7.2	9.2	7.5	4.6	13.7	3.6	11.2	5.5	4.9	18.7	10.7	8.8	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1	11.9	21.7	21.7	27.4	5.3	24.1	30.3	43.3	28.1	12.5	47.1	17.7	37.1	101.2	42.9	1.5	21.1	59.4	0.0	21.2	21.2	16.6	28.0	17.3	147.7	52.8	33.4	8.6	31.3	25.4	3.2	20.1	21.3	20.3	60.5	44.3	33.5	28.9	49.2	23.0	159.0	20.1	6.5	18.9	4.1	3.3	5.6	34.6	15.2	47.0	22.5
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434369-55579214	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;pituitary gland: 14.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 14.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10.0	1.3	3.6	0.8	14.8	12.5	14.6	7.0	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0.0	0.9	0.0	1.0	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.3	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10.0	14.6	3.3	0.0	2.2	0.0	0.0	0.0	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	1.4	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75362104	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797"	Approved					NA	NA					"CAB016797: , HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	5.6	28.9	12.4	8.7	31.1	12.1	16.4	14.4	36.3	13.9	23.0	10.9	7.1	18.9	9.0	14.4	35.0	6.5	8.2	4.0	21.8	16.5	12.1	53.5	12.1	7.0	9.8	19.4	15.2	8.4	16.2	11.4	9.2	29.6	12.4	19.7	7.8	12.4	4.5	3.4	36.1	19.0	6.8	17.0	7.9	14.6	14.0	8.8	13.9	12.5	23.2	12.4	6.2	18.1	4.3	12.5	23.2	11.0	9.5	6.5	5.1	15.3	6.0	61.4	21.1	13.0	25.2	15.4	4.4	12.4	9.0	20.1	22.6	37.8	13.7	16.1	7.1	58.9	19.4	31.9	51.8	9.6	4.6	11.7	10.5	9.1	17.5	19.2	8.7	7.7	16.3	30.5	31.5	15.6	4.5	7.2	19.7	11.2	21.0	14.2	10.0	16.0	8.8	26.2	3.9	4.5	11.3	18.4	19.6	37.1	35.8	21.3	9.7	9.7	10.1	8.8	22.1	10.0	22.9	8.4	4.9	7.3	5.2	7.5	6.7	8.5	18.9	7.1	17.1	10.1	6.7	11.0	6.3	6.1	6.9	5.1	4.3	4.6	6.4	12.5	4.2	4.5	6.2	23.2	9.5	7.4	3.9	6.5	5.1	12.4	31.1	14.4	36.3	21.8	16.5	9.8	19.4	29.6	8.8	17.9	33.4	7.5	8.5	36.9	20.9	5.7	12.7	32.1	22.7	26.2	17.7	16.3	3.3	12.1	38.1	7.6	33.8	0.0	18.8	21.6	10.5	13.9	24.2	22.5	11.5	38.1	41.2	9.8	19.3	19.5	8.6	12.3	15.1	2.8	50.6	10.3	11.9	20.1	5.6	6.3	13.1	12.9	8.2	21.0	14.0	80.0	39.0	8.7	20.2	17.3
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	14.9	7.2	120.5	13.8	7.0	27.9	8.1	2.4	9.5	3.4	6.9	12.5	21.6	15.9	5.4	3.4	80.3	11.8	30.0	69.5	3.6	3.4	36.0	5.9	6.6	16.9	11.1	12.8	4.2	15.3	8.4	18.1	7.2	2.1	3.5	14.8	10.5	43.5	2.8	6.9	11.5	15.6	21.6	6.0	3.8	8.3	16.9	17.6	53.4	23.2	10.3	5.0	12.3	6.2	3.6	18.2	9.6	17.0	4.2	2.6	13.0	2.7	2.2	5.9	8.9	21.7	2.3	15.4	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1	62.5	124.5	45.6	35.9	96.3	27.9	7.4	56.0	48.2	36.4	45.4	49.1	20.4	11.6	30.6	5.0	19.7	86.8	0.0	52.0	35.5	35.0	65.2	59.8	78.4	20.7	46.1	88.4	23.4	20.8	1.8	11.8	17.2	25.3	78.5	44.0	19.7	36.3	30.9	13.4	17.7	43.3	0.0	24.9	14.1	7.8	206.6	37.2	20.1	31.2	65.0
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.8	15.4	29.0	38.4	72.4	34.0	15.3	17.4	23.5	16.5	30.1	12.7	29.8	23.9	35.9	18.8	24.3	18.0	21.3	37.9	25.8	26.1	19.7	31.4	16.8	24.2	18.4	9.9	49.2	29.6	15.9	17.7	16.7	19.4	28.2	16.5	10.7	13.9	17.9	15.5	15.1	6.4	21.5	44.1	10.9	19.3	29.1	25.8	26.4	49.4	21.9	18.9	40.9	6.4	19.0	28.7	23.7	16.7	20.0	16.2	11.1	17.8	14.2	7.1	14.8	8.8	18.4	26.5	15.9	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5	68.5	94.4	20.8	34.3	13.3	18.5	62.9	81.5	24.1	47.8	34.9	13.7	57.8	71.3	28.8	7.4	26.4	50.3	0.0	31.4	21.8	24.2	32.2	65.9	203.2	70.1	14.3	31.7	31.3	50.9	9.3	31.9	35.3	8.5	103.6	42.6	44.1	23.2	24.6	48.1	50.5	15.4	6.5	20.0	15.9	22.2	15.1	54.3	13.1	51.1	31.4
IDI1		ENSG00000067064	"Isopentenyl-diphosphate delta isomerase 1"	Q13907	10	1039152-1049170	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039169	Approved					NA	NA					"HPA039169: AB_10674280"	"unprognostic (1.61e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.72e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.61e-2)"	13.6	30.4	23.1	15.2	28.3	47.8	68.8	16.4	39.2	8.8	16.1	22.5	8.0	27.9	7.7	12.6	19.2	6.5	9.9	9.7	23.0	29.2	15.3	67.6	15.6	15.5	21.7	25.3	13.4	13.7	12.3	20.6	10.0	55.9	22.3	15.0	16.9	9.9	7.1	35.1	13.7	17.6	8.3	30.6	17.5	12.9	10.2	14.4	8.5	9.8	16.8	16.3	12.5	11.1	16.1	8.9	36.4	19.6	14.5	18.4	14.8	25.5	9.6	51.3	12.5	21.5	46.9	7.5	10.8	12.2	12.5	26.6	25.2	40.3	23.2	7.1	11.7	29.9	22.3	28.4	51.0	11.4	8.0	26.9	22.6	14.5	28.7	25.1	8.7	11.2	29.6	21.5	34.9	4.6	5.3	9.7	21.6	15.4	32.7	21.0	20.0	16.6	14.3	20.7	20.8	5.7	19.4	24.5	25.8	54.3	22.7	8.0	9.6	13.7	28.3	28.3	16.5	29.4	29.3	9.8	6.9	3.9	20.1	7.7	19.0	17.9	43.7	8.6	25.9	6.2	36.4	9.4	21.9	18.2	17.1	18.4	16.1	14.2	15.2	8.6	14.9	10.7	15.8	25.1	14.5	19.6	8.9	14.9	14.8	23.1	28.3	16.4	39.2	23.0	29.2	21.7	25.3	55.9	14.4	68.5	123.1	100.7	66.5	79.6	74.8	59.3	50.9	54.9	45.5	38.4	35.3	59.8	127.6	39.4	221.4	48.6	87.1	0.0	90.3	44.8	52.3	86.3	97.1	52.9	70.4	60.4	101.5	63.8	60.6	68.2	24.5	54.0	126.5	66.7	65.1	108.3	56.5	59.6	28.0	48.2	63.2	25.8	71.4	47.2	43.8	126.5	156.5	103.8	41.3	93.4
IDI2	IPPI2	ENSG00000148377	"Isopentenyl-diphosphate delta isomerase 2"	Q9BXS1	10	1018907-1025859	"Enzymes, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	125	"skeletal muscle: 141.6"	"Cell type enhanced"	"Detected in some"	13	"Club cells: 1.2;Horizontal cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;NB-4: 2.7;NTERA-2: 1.5;SK-MEL-30: 3.4"									HPA041254			Uncertain	Vesicles		NA	NA			Vesicles		"HPA041254: AB_10794270"									"unprognostic (6.69e-3)"	"unprognostic (4.05e-2)"				"unprognostic (1.64e-1)"				1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	141.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.7	0.5	0.1	0.0	0.7	0.0	0.8	0.1	0.0	1.0	0.0	0.0	0.4	0.4	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.5	0.0	0.3	0.9	1.4	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.3	2.7	1.5	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.4	0.2	1.0	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 204.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 35.6;Hep G2: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.5	4.0	6.0	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4.0	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15.0	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0.0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2.0	6.0	0.0	1.6	0.0	4.3	0.0	0.0	0.9	2.7	7.1	2.9	1.1	204.0	2.1	0.0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0.0	7.5	1.4	0.0	8.1	0.0	0.5	12.9	7.1	1.0	1.5	2.3	10.2	0.0	0.0	1.4
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported		Approved	Cytosol		NA	NA			Cytosol		"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"	21.1	22.9	17.9	9.9	38.8	5.0	14.7	22.5	33.9	11.2	16.9	37.7	5.8	26.4	16.6	12.5	23.4	11.0	12.1	17.8	19.0	17.3	8.4	33.8	19.7	8.3	49.5	14.9	25.7	15.8	10.4	22.7	10.3	42.7	24.0	10.7	13.2	11.0	13.2	24.5	26.2	10.3	12.2	33.3	7.1	14.1	13.8	46.9	6.0	7.5	9.8	8.3	12.3	11.8	4.8	8.0	5.2	3.3	2.7	8.3	5.0	18.1	5.9	19.2	8.2	26.1	25.1	5.4	7.0	49.9	8.7	17.1	19.4	14.5	3.9	6.0	13.6	63.9	8.6	16.9	29.4	3.5	3.8	9.1	9.7	9.7	12.5	23.8	3.5	6.8	24.7	11.2	16.2	7.0	6.0	7.2	19.3	9.4	23.5	7.4	6.1	7.6	5.0	31.2	2.9	5.3	9.0	5.9	23.7	22.6	10.0	11.2	9.9	8.3	6.4	7.2	8.6	10.2	8.8	10.7	10.3	8.4	9.1	5.4	8.6	7.3	7.9	10.8	15.6	4.4	5.2	3.3	3.5	6.9	3.0	4.7	4.8	5.0	8.3	3.8	3.0	4.2	6.2	0.0	2.7	2.5	8.0	2.3	5.0	17.9	38.8	22.5	33.9	19.0	17.3	49.5	14.9	42.7	46.9	11.9	33.7	11.5	3.8	32.7	12.9	13.4	12.7	8.1	7.9	10.4	3.9	3.4	0.0	9.7	4.2	9.8	5.3	23.3	15.0	5.1	25.7	14.9	3.5	23.8	8.1	22.3	18.9	9.8	7.8	5.3	19.5	5.0	20.3	19.0	10.0	8.7	10.9	0.0	12.7	3.8	15.2	0.0	10.0	13.6	9.4	47.2	5.3	5.0	10.0	4.1
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327623-165343160	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 171.6"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 234.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 69.5;Karpas-707: 68.2;RPTEC TERT1: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056127	Enhanced					NA	NA					"HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"	5.0	26.5	17.1	6.7	23.7	3.5	21.5	7.7	29.6	15.6	12.6	22.8	4.0	22.6	6.1	31.5	44.9	7.1	7.4	5.8	18.8	20.8	16.3	171.6	30.0	6.4	13.1	18.6	18.0	7.5	10.9	7.0	7.4	41.1	19.1	10.8	12.1	10.6	4.7	2.2	22.5	20.7	5.7	33.5	4.3	10.3	15.8	12.5	4.3	7.5	17.6	12.9	8.6	17.7	21.2	10.1	6.2	9.8	12.1	20.8	15.8	14.0	3.4	33.1	6.0	16.4	52.8	6.2	5.7	25.9	7.4	20.5	6.6	60.4	7.0	3.4	6.9	69.5	11.6	16.6	59.9	8.2	5.9	10.2	3.1	3.6	20.3	33.1	5.6	4.4	32.6	39.4	27.1	16.8	10.1	9.5	9.1	5.5	68.2	12.1	7.2	5.0	9.2	19.0	7.4	3.4	2.6	3.6	21.0	65.8	16.5	6.6	4.9	8.9	12.7	5.3	21.2	5.9	7.1	10.9	3.4	6.1	3.0	3.9	12.6	13.2	9.2	7.3	5.7	4.6	6.2	4.6	4.5	19.0	5.9	14.2	21.2	18.3	17.6	7.8	18.9	20.0	20.8	3.4	12.1	9.8	10.1	15.8	15.8	17.1	23.7	7.7	29.6	18.8	20.8	13.1	18.6	41.1	12.5	47.6	144.4	35.8	51.9	32.1	27.2	5.8	45.9	68.3	60.3	66.3	25.5	47.4	29.9	52.5	2.8	17.5	70.9	0.0	62.6	72.4	27.9	84.9	48.3	234.0	24.0	33.4	58.1	29.4	29.7	4.5	23.0	15.0	30.4	36.1	42.1	22.3	58.7	24.6	17.7	36.0	46.7	19.4	20.2	7.4	14.4	100.6	102.9	22.4	21.1	123.4
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		30000	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.7	9.5	15.9	10.3	5.4	11.9	9.0	7.3	7.7	5.0	4.3	25.1	37.5	7.1	11.9	4.3	18.6	22.0	7.1	39.0	1.4	4.5	12.1	5.2	5.2	38.1	10.9	3.3	3.7	9.4	7.5	13.3	4.2	2.5	5.3	17.5	14.6	3.9	2.7	34.5	11.3	17.0	19.1	5.1	9.3	11.8	4.6	18.5	14.8	9.3	16.1	5.4	18.3	4.2	5.3	3.4	20.8	15.0	11.5	4.7	9.5	8.3	4.1	11.0	4.8	24.4	5.6	16.4	7.7	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6	23.8	45.3	22.0	10.8	13.5	19.2	11.9	28.1	10.7	15.9	19.2	5.9	20.1	21.6	27.8	48.8	12.0	73.8	0.0	53.8	25.2	18.8	15.9	16.1	17.8	31.6	22.3	31.6	23.9	28.8	70.6	7.5	16.4	20.3	45.9	40.3	14.8	24.2	38.6	8.5	16.5	16.5	6.5	14.2	32.0	13.5	18.9	40.8	32.0	29.4	16.7
MVK	"LRBP, MK"	ENSG00000110921	"Mevalonate kinase"	Q03426	12	109573255-109598117	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.6;Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016961, HPA044110"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA016961: AB_1854220, HPA044110: "	"unprognostic (3.10e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.28e-1)"	4.7	14.3	6.8	5.9	11.7	6.8	11.2	6.3	13.1	7.1	7.8	16.7	5.1	11.5	4.2	9.5	23.0	5.1	5.3	6.7	7.8	9.0	16.5	33.1	8.7	4.9	12.5	8.3	8.5	9.3	7.0	6.5	5.5	22.5	9.0	6.3	6.4	8.1	5.8	6.3	19.5	6.9	3.7	18.0	3.8	6.1	17.5	10.5	2.8	11.9	8.5	8.8	5.5	9.9	11.5	7.4	3.4	5.9	8.3	12.2	5.4	12.4	10.5	12.8	6.3	4.1	10.1	6.8	4.5	8.4	11.9	13.0	15.0	15.1	8.7	3.5	4.5	19.3	15.1	13.5	21.3	5.8	8.6	9.6	4.7	7.1	22.5	12.7	4.9	6.0	11.0	18.0	21.5	5.8	5.1	8.0	8.5	8.0	8.3	5.3	15.7	5.1	15.8	10.7	5.8	16.2	4.6	9.8	17.1	27.4	18.4	11.8	10.3	8.9	25.2	6.3	5.3	23.2	8.7	7.1	5.5	7.1	5.2	5.8	7.0	9.2	12.9	6.5	12.8	7.4	0.7	5.9	3.4	12.2	5.8	9.9	8.4	7.4	11.6	7.4	11.5	11.7	8.3	1.7	8.3	3.7	6.2	6.2	5.4	6.8	11.7	6.3	13.1	7.8	9.0	12.5	8.3	22.5	10.5	11.9	11.3	13.4	4.5	4.1	10.2	4.4	15.3	9.4	10.3	14.0	17.7	28.9	18.3	11.3	59.6	5.6	12.5	0.0	15.7	10.9	4.7	4.6	1.1	18.5	13.2	58.8	8.6	6.2	4.1	29.2	7.5	3.3	6.8	17.2	7.2	10.0	9.4	2.9	6.7	32.6	11.5	6.5	4.7	19.9	19.0	7.4	40.0	7.5	9.8	4.5
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	40.6	14.9	20.4	10.6	17.6	13.4	11.5	8.1	10.9	14.8	18.8	20.6	22.2	20.1	27.3	11.0	55.0	20.9	26.5	37.5	13.1	6.7	15.2	8.2	14.6	20.9	12.8	8.2	6.7	16.4	14.5	28.9	7.3	6.4	13.7	8.9	13.6	9.1	11.2	18.0	8.0	10.7	8.1	20.4	18.0	6.0	14.8	16.5	30.7	16.8	7.4	8.4	7.2	10.9	8.5	14.8	7.2	10.5	11.6	6.9	11.4	16.6	15.6	12.9	8.6	34.6	12.8	12.9	6.5	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3	11.9	14.7	9.7	9.8	9.6	3.8	21.0	15.3	18.7	10.3	12.2	0.0	18.3	8.3	16.9	8.7	7.4	12.0	0.0	17.6	18.3	9.8	7.8	8.1	26.3	16.1	1.6	5.8	8.0	8.3	5.9	7.8	9.3	5.0	15.4	8.7	10.3	16.2	7.8	8.5	11.5	5.4	0.0	8.2	3.7	8.2	10.7	15.6	5.7	9.4	15.3
PMVK	"HUMPMKI, PMK, PMKA"	ENSG00000163344	"Phosphomevalonate kinase"	Q15126	1	154924734-154936991	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029900	Approved					NA	NA					"HPA029900: AB_10601390"	"unprognostic (2.52e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.47e-2)"	"unprognostic (8.22e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.10e-1)"	21.0	28.3	31.3	15.9	34.0	7.2	19.4	13.9	31.7	17.0	18.9	25.3	10.2	26.4	12.1	14.7	30.1	20.2	15.7	24.7	23.9	23.9	26.9	39.3	16.2	18.7	29.6	29.3	18.8	22.2	26.8	26.1	13.8	22.4	17.0	12.0	22.2	18.8	15.9	39.8	26.1	25.2	16.7	23.9	20.5	21.8	15.9	22.8	9.9	17.8	25.3	18.9	12.2	22.8	29.1	22.9	20.4	47.3	13.4	30.4	17.7	11.7	16.6	10.7	16.8	9.9	7.1	11.4	9.5	6.4	8.7	8.3	6.7	23.3	16.7	18.2	10.7	9.5	11.5	14.5	14.1	4.0	23.4	6.6	7.6	22.4	6.2	9.2	11.6	7.0	8.4	13.1	15.8	11.2	4.4	8.7	15.1	8.1	51.9	9.0	23.5	9.1	11.2	9.7	27.1	21.3	13.9	7.0	38.5	14.6	8.6	9.0	21.5	10.2	17.8	11.6	8.4	34.0	20.6	7.4	8.5	7.0	20.1	14.1	42.2	33.7	29.5	14.1	18.7	10.9	4.6	19.8	20.4	17.5	46.9	27.9	29.1	24.0	17.8	22.1	23.9	15.7	15.7	1.7	13.4	47.3	22.9	30.4	17.7	31.3	34.0	13.9	31.7	23.9	23.9	29.6	29.3	22.4	22.8	53.6	29.1	50.4	97.4	62.0	37.2	44.8	76.5	12.0	20.5	50.6	7.9	202.5	225.5	58.9	6.4	26.7	90.5	0.0	62.5	77.8	60.1	55.3	21.9	125.4	120.4	35.0	63.8	33.7	65.6	10.4	39.4	42.6	62.4	49.5	62.3	77.7	52.4	54.7	44.9	190.8	21.7	32.3	55.9	42.4	43.2	79.2	190.4	59.5	69.9	62.7
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292453-121308694	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 143.5"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 117.3;Ito cells: 163.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"	10.9	15.3	16.9	5.5	18.4	2.7	23.3	10.4	26.9	9.4	9.4	17.8	24.5	17.4	6.8	30.1	19.5	7.2	7.4	9.4	18.7	19.6	19.7	143.5	10.1	5.5	20.8	17.8	7.8	8.9	17.5	14.7	6.3	40.8	40.3	8.6	8.2	9.5	24.0	3.9	7.7	13.4	7.6	43.4	4.1	8.8	9.7	16.0	3.7	10.4	8.2	8.1	14.0	14.6	6.0	9.8	7.5	6.3	6.8	10.0	3.8	6.8	3.4	51.8	11.0	20.1	17.5	7.3	7.7	14.5	5.2	9.2	21.6	25.5	6.5	24.4	8.4	41.5	25.7	16.1	19.5	5.1	3.2	22.0	9.6	22.6	17.2	16.4	6.0	3.3	14.3	16.0	16.4	16.9	4.4	7.8	6.4	6.2	9.4	24.0	7.1	2.4	7.9	16.1	19.8	11.0	3.4	13.0	5.5	36.5	30.8	13.7	7.7	17.7	4.0	10.1	36.2	16.2	10.4	14.9	5.0	8.1	8.8	3.6	1.8	2.9	8.7	1.9	13.4	8.6	7.5	4.8	1.2	5.0	6.3	8.5	6.0	6.8	6.0	8.5	6.0	10.0	9.5	0.4	6.8	4.5	9.8	6.9	3.8	16.9	18.4	10.4	26.9	18.7	19.6	20.8	17.8	40.8	16.0	17.9	26.4	26.2	53.7	8.7	21.9	17.8	15.3	14.7	18.2	19.2	29.5	13.8	5.0	17.3	2.2	8.4	23.5	0.0	25.4	14.2	17.3	59.7	17.3	117.3	17.9	22.3	13.8	163.9	25.6	1.0	17.8	15.1	18.6	22.6	12.7	40.5	14.5	11.4	15.9	14.6	29.6	12.9	16.7	6.0	13.0	13.6	15.6	21.7	11.9	45.5
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103518-53124538	"Enzymes, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 60.8"	"Cell type enhanced"	"Detected in single"	15	"Club cells: 1.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.8;Hep G2: 21.4;U-266/70: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.5	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	0.9	16.4	0.2	0.2	12.3	0.7	0.3	0.2	0.9	0.4	0.2	0.2	0.0	0.6	4.2	0.2	0.6	0.2	0.2	0.4	0.2	0.0	0.3	0.2	0.2	0.6	0.0	0.2	0.4	0.2	0.2	0.4	60.8	0.2	0.3	2.2	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.3	0.5	3.7	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.4	9.8	0.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.9	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.3	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.1	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.7	0.0	1.5	2.7	0.0	0.0	0.4	1.5	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.8	10.0	60.2	17.3	18.7	31.8	6.1	6.8	21.0	9.3	17.1	13.6	37.9	17.8	9.9	8.4	37.4	19.8	25.1	37.7	10.8	14.7	53.0	50.9	6.8	34.7	27.6	5.9	15.0	21.7	40.4	27.7	22.9	6.0	10.1	12.6	29.0	34.7	7.5	42.7	20.6	7.5	24.9	17.8	6.9	9.1	11.0	24.3	65.6	29.8	18.8	9.5	14.0	45.0	14.0	20.2	12.0	15.6	9.9	3.8	13.6	4.5	6.0	6.3	12.8	24.4	6.4	18.2	6.6	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7	56.6	84.1	38.7	41.4	20.4	26.3	6.1	28.1	108.4	52.4	50.6	47.1	81.6	6.6	50.5	18.8	11.2	44.6	46.7	73.0	111.6	54.5	79.8	41.4	15.7	48.5	139.8	30.4	12.3	13.0	9.6	22.2	16.0	20.3	154.1	29.4	23.5	64.9	21.0	10.3	2.9	47.5	25.8	29.0	131.6	152.1	77.9	181.6	17.5	20.4	100.4
TM7SF2	"ANG1, DHCR14A, NET47"	ENSG00000149809	"Transmembrane 7 superfamily member 2"	O76062	11	65111845-65116384	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.1"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 176.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 22.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 22.1;RPTEC TERT1: 25.4;T-47d: 49.4"					"Low region specificity"	"Detected in all"			"HPA030691, HPA072704"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"HPA030691: AB_10602480, HPA072704: AB_2686551"	"unprognostic (1.62e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.06e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (8.49e-8)"	"unprognostic (8.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.44e-2)"	27.7	78.1	6.9	2.2	12.5	2.0	10.0	5.6	21.7	4.7	3.1	22.4	5.1	4.8	1.5	11.0	11.5	6.4	8.5	28.2	7.4	6.6	8.3	38.6	5.1	1.7	10.3	9.6	13.5	22.6	11.8	6.2	2.2	13.2	19.8	2.3	5.4	28.5	3.3	3.3	17.9	2.8	1.3	7.3	1.9	8.8	5.3	8.8	1.9	7.4	13.6	10.4	2.6	6.1	7.4	22.6	1.8	1.0	7.3	7.6	3.0	2.6	3.6	8.5	12.2	3.4	0.2	5.4	0.6	1.3	1.0	1.1	8.8	12.4	5.4	9.6	0.4	0.3	4.3	3.7	6.0	0.7	5.2	1.9	3.3	1.0	17.7	6.9	1.3	3.7	1.5	1.8	4.9	0.6	4.0	0.9	10.3	1.9	4.2	0.3	22.1	2.3	5.8	4.6	5.6	4.1	7.2	0.4	12.7	25.4	3.9	9.6	10.8	0.4	9.3	2.1	5.6	49.4	3.6	0.6	0.1	1.3	1.2	0.8	9.6	6.0	3.1	0.8	2.1	0.3	0.5	1.0	1.8	5.5	0.8	4.3	7.1	3.5	4.5	0.9	7.4	7.6	5.5	0.7	7.3	0.5	22.6	3.1	3.0	6.9	12.5	5.6	21.7	7.4	6.6	10.3	9.6	13.2	8.8	8.9	36.6	11.1	5.3	1.6	15.6	89.9	50.9	6.7	5.7	41.8	9.8	64.7	14.9	20.7	26.9	4.5	21.7	0.0	24.2	1.7	3.3	37.3	6.9	79.7	12.7	23.8	57.1	4.3	6.3	49.4	9.2	3.5	11.8	13.6	16.5	176.3	28.8	11.5	2.1	62.4	21.2	12.9	2.3	10.9	9.4	6.0	68.7	8.5	12.4	8.4
